Consequently, PCSK9-targeting agents, such as anti-PCSK9 antibodies, vaccines, antisense RNAi, and some drugs (acRoots, lupin peptides, and pseurotin A) have been developed to target the regulation of PCSK9 for potential cancer treatment strategies. This evidence concerns the gene PCSK9 and cancer.